Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Breast Neoplasms 13Neoplasms 12Colorectal Neoplasms 12Pain 11Pain, Postoperative 9Prostatic Neoplasms 7Lung Neoplasms 7Agnosia 6Colonic Neoplasms 5Cancer Pain 5Neuralgia 4Keratosis, Actinic 4Head and Neck Neoplasms 4Liver Neoplasms 3Leiomyoma 3Chronic Pain 3Thyroid Neoplasms 2Stomatitis 2Stomach Neoplasms 2Recurrence 2Pilonidal Sinus 2Oropharyngeal Neoplasms 2Neuroma 2Neoplasm Metastasis 2Myofibroma 2Mucositis 2Inflammatory Bowel Diseases 2Ileus 2Diverticulitis 2Carcinoma, Non-Small-Cell Lung 2

Interventions

pembrolizumab 300Nivolumab 273Ipilimumab 250aldesleukin 137Cyclophosphamide 136Interleukin-2 105trametinib 82dabrafenib 76Temozolomide 75Dacarbazine 74Vemurafenib 71fludarabine 68fludarabine phosphate 62Biopsy 49binimetinib 47sargramostim 44Radiosurgery 44Bevacizumab 43Paclitaxel 42encorafenib 40incomplete Freund's adjuvant 39atezolizumab 38Radiotherapy 37Specimen Handling 36Cisplatin 36CTLA-4 Antigen 36Magnetic Resonance Spectroscopy 35Carboplatin 35cobimetinib 34Introns 33

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Melanoma × Lidocaine × Clear all
NCT03699995 2026-04-08

MoleMapper, Visiomed, and Confocal Microscopy in Screening Participants for Melanoma

OHSU Knight Cancer Institute

Phase NA Terminated
17 enrolled
Dermatologic

Melanoma, Nevus, Pigmented

Data powered by HemOnc (CC BY 4.0) Colophon âš¡